Scholar Rock to Present New Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC th Annual Meeting
| SRRK Stock | USD 29.92 3.25 12.19% |
About 52% of Scholar Rock's institutional investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Scholar Rock Holding suggests that some traders are interested. Scholar Rock's investing sentiment shows overall attitude of investors towards Scholar Rock Holding.
Scholar |
Scholar Rock , a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy , card
Read at businesswire.com
 |
Scholar Rock Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Scholar Rock can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Scholar Rock Fundamental Analysis
We analyze Scholar Rock's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Scholar Rock using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Scholar Rock based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Ratio
Current Ratio Comparative Analysis
Scholar Rock is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Scholar Rock Holding Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Scholar Rock stock to make a market-neutral strategy. Peer analysis of Scholar Rock could also be used in its relative valuation, which is a method of valuing Scholar Rock by comparing valuation metrics with similar companies.
Peers
Scholar Rock Related Equities
| HOWL | Werewolf Therapeutics | 6.74 | ||||
| MLYS | Mineralys Therapeutics, | 5.22 | ||||
| ANAB | AnaptysBio | 5.20 | ||||
| BDTX | Black Diamond | 4.53 | ||||
| KROS | Keros Therapeutics | 3.86 | ||||
| ARVN | Arvinas | 2.99 | ||||
| CGEM | Cullinan Oncology | 2.62 | ||||
| RLAY | Relay Therapeutics | 2.37 | ||||
| GLUE | Monte Rosa | 1.68 | ||||
| RNA | Avidity Biosciences | 1.62 | ||||
| STOK | Stoke Therapeutics | 1.42 | ||||
| PLRX | Pliant Therapeutics | 1.01 | ||||
| DSGN | Design Therapeutics | 0.90 | ||||
| IDYA | Ideaya Biosciences | 0.71 | ||||
| MGTX | MeiraGTx Holdings | 0.17 | ||||
| RVMD | Revolution Medicines | 0.05 | ||||
| IKNA | Ikena Oncology | 1.16 | ||||
| PASG | Passage Bio | 5.56 | ||||
| IGMS | IGM Biosciences | 9.01 |
Check out Scholar Rock Hype Analysis, Scholar Rock Correlation and Scholar Rock Performance. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Scholar Rock. If investors know Scholar will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Scholar Rock listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.36) | Quarterly Revenue Growth (1.00) | Return On Assets (0.67) | Return On Equity (1.83) |
The market value of Scholar Rock Holding is measured differently than its book value, which is the value of Scholar that is recorded on the company's balance sheet. Investors also form their own opinion of Scholar Rock's value that differs from its market value or its book value, called intrinsic value, which is Scholar Rock's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Scholar Rock's market value can be influenced by many factors that don't directly affect Scholar Rock's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Scholar Rock's value and its price as these two are different measures arrived at by different means. Investors typically determine if Scholar Rock is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Scholar Rock's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.